1.09

3.81% 0.04

After Hours: 1.09

Telomir Pharmaceuticals Inc (TELO)

Overview News Price History Discussions Forecast

Telomir Pharmaceuticals Inc stock is traded at $1.09, with a volume of 53,441. It is up +3.81% in the last 24 hours and down -12.10% over the past month. Telomir Pharmaceuticals Inc is a preclinical-stage biotechnology company focused on the development of small-molecule therapeutics designed to address upstream biological drivers of aging and age-related diseases rather than treating symptoms alone. The company's research targets fundamental cellular processes associated with disease progression and functional decline, including metal-ion dysregulation, oxidative stress, epigenetic regulation, mitochondrial dysfunction, and telomere integrity. Telomir's investigational compound, Telomir-1 (Zn-Telomir), is a novel orally administered small molecule engineered to modulate intracellular metal balance particularly iron, copper, calcium, and zinc.

Previous Close:

$1.05

Open:

$1.05

24h Volume:

53,441

Relative Volume:

0.53

Market Cap:

$74.96M

Revenue:

Net Income/Loss:

$-9.22M

P/E Ratio:

-3.7367

EPS:

-0.2917

Net Cash Flow:

$-4.60M

1W Performance:

-6.03%

1M Performance:

-12.10%

6M Performance:

+0.00%

1Y Performance:

-30.57%

1-Day Range:

$1.05

$1.135

1-Week Range:

$1.04

$1.19

52-Week Range:

$0.8885

$2.091

Telomir Pharmaceuticals Inc Stock (TELO) Company Profile

Name

Telomir Pharmaceuticals Inc

Sector

Healthcare (1080)

Industry

Biotechnology (604)

Phone

786-396-6723

Address

100 SE 2ND ST, MIAMI

Employee

Twitter

Next Earnings Date

2026-08-13

Latest SEC Filings

TELO's Discussions on Twitter

Compare TELO vs VRTX, REGN, ARGX, RVMD, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
TELO Telomir Pharmaceuticals Inc	1.09	76.34M	0	-9.22M	-4.60M	-0.2917
VRTX Vertex Pharmaceuticals Inc	505.75	133.25B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	803.48	82.16B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	851.29	54.80B	4.16B	1.29B	734.26M	19.58
RVMD Revolution Medicines Inc	203.71	43.99B	742.00K	-1.37B	-1.07B	-7.0731
ONC Beone Medicines Ltd Adr	347.48	40.62B	5.76B	514.49M	1.10B	4.4813

Telomir Pharmaceuticals Inc Stock (TELO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-21-25	Initiated	Rodman & Renshaw	Buy

Telomir Pharmaceuticals Inc Stock (TELO) Latest News

03:51 AM

Telomir Flags Substantial Doubt About Ability to Continue as Going Concern - Minichart

03:51 AM

Aug 13, 2026

Telomir Pharmaceuticals (NASDAQ:TELO) Releases Quarterly Earnings Results - MarketBeat

Aug 13, 2026

Aug 12, 2026

Telomir Pharmaceuticals (NASDAQ:TELO) Stock Price Down 3.4%Should You Sell? - MarketBeat

Aug 12, 2026

Aug 10, 2026

Telomir-Zn Preclinical Data Support Advancement in TNBC - TipRanks

Aug 10, 2026

Telomir Pharmaceuticals Announces Peer-Reviewed Publication of Preclinical Telomir-Zn Data Showing Tumor Suppression in Prostate and Triple-Negative Breast Cancer Models - Quiver Quantitative

Aug 10, 2026

Aug 04, 2026

Telomir Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Aminov Erez - Moomoo

Aug 04, 2026

Jul 29, 2026

Telomir Pharmaceuticals, Inc. Common Stock (NASDAQ: TELO) Stock Price, News & Analysis - Kalkine

Jul 29, 2026

Jul 27, 2026

Telomir Pharmaceuticals (TELO) grants 50,000 stock options to director - Stock Titan

Jul 27, 2026